NEW YORK, Oct. 20 (GenomeWeb News) - Proteome Systems of Australia has licensed a potential biomarker for ovarian cancer from the Children's Hospital at Westmead and Westmead Millennium Institute of Sydney, the company said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.
Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.
CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.
In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.
